All Stories

  1. Hospitalization risk in bipolar disorder patients treated with lurasidone versus other atypical antipsychotics

    Article • Current Medical Research and Opinion, April 2018, Taylor & Francis

    Antony Loebel

  2. Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia

    Article • CNS Spectrums, December 2013, Cambridge University Press

    Antony Loebel

  3. Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US

    Article • ClinicoEconomics and Outcomes Research, September 2013, Taylor & Francis

    Antony Loebel